Preclinical
The researchers identified a group of centyrins that blocked the action of five toxins generated by Staphylococcus aureus, the bacteria that causes Staph infections.
A study published in Clinical Chemistry earlier this month has linked sperm with more DNA damage to repeated miscarriages. Recurring miscarriages, defined as three or more consecutive miscarriages before 20 weeks of pregnancy, occur in 1-2 percent of couples.
The rate of incidence of infection by Naegleria fowleri in the U.S. is very, very low. But there’s something about picking up an incurable, brain-eating amoeba by swimming in freshwater lakes and rivers that understandably freaks people out.
After conducting a routine research-and-development review, Pfizer is easing away from preclinical biosimilar development. The bottom line is the company is ending five preclinical programs in its biosimilar area and cutting 150 positions.
Artificial intelligence technology has an established home in drug design for many developers. Now, researchers are seeing it as a potential tool in driving therapeutic choices in the treatment of ovarian cancer.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Brain plasticity refers to the brain’s ability to change throughout life. When young, the brain is highly plastic, but becomes less so as we age. Too much plasticity can be a problem, but it’s necessary for the brain’s ability to repair itself or reorganize itself after injury or when learning new things.
As a valued member of our BioSpace community, we are eager to hear more from you and other readers in 2019. Let us know which topics you want to hear more about.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Researchers with the Francis Crick Institute and the Institute of Cancer Research recently published research suggesting that a new class of drugs that is helpful in treating breast cancers could help treat some of the hardest-to-treat lung cancers.
PRESS RELEASES